Governing Board

The Governing Board is the main decision-making body of the Innovative Medicines Initiative (IMI). It carries the overall responsibility for the operations of the undertaking and oversees the implementation of its activities. It therefore guarantees the fulfilment of the objectives set by the organisation.

The Governing Board is composed of 10 Board members representing equally our two Founding Members: 5 from the European Commission, representing the European Community, and 5 from the European Federation of Pharmaceutical Industries and Associations (EFPIA), representing the research-based pharmaceutical industry in Europe. In addition, our Associated Partners may take part in Governing Board discussions that concern their association, although they do not have voting rights.

The way the Governing Board works is set out in the Governing Board Rules of Procedure. Lists of the decisions taken by the Governing Board under the IMI2 programme are published on this page.

The roles of chair and deputy chair are held alternately by representatives of the European Commission and representatives of EFPIA.  

 

Members of the IMI Governing Board

Representatives of the European Commission

 

jack_metthey220.jpg

Jack Metthey

Chair of the IMI Governing Board
Acting Deputy Director-General responsible for Research Programmes within the Directorate-General for Research and Innovation, European Commission

 

irene_norstedt220b.jpg

 

Irene Norstedt

Head of Unit responsible for Innovative and Personalised Medicine within the Directorate-General for Research and Innovation, European Commission

CV

 

 

carlo_pettinelli220.jpg

Carlo Pettinelli

Director responsible for Consumer, Environmental and Health Technologies within the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission

CV

 

andrzej_rys220.jpg

Andrzej Jan Rys

Director responsible for Health systems, medical products and innovation within the Directorate-General for Health and Food Safety, European Commission

CV

 

 

line_matthiessen220.jpg

Line Matthiessen

Acting Director responsible for the Health Directorate within the Directorate-General for Research and Innovation, European Commission

CV

 

 

 

Representatives of EFPIA

 

jean_christophe_tellier220.jpg

Jean-Christophe Tellier

Deputy Chair of the IMI Governing Board
CEO of UCB, member of the EFPIA Board, Chair of the EFPIA Innovation Board Sponsored Committee

CV

 

nathalie_moll220.jpg

Nathalie Moll

Director General of EFPIA

CV

 

 

salah_dine_chibout220.jpg

Salah-Dine Chibout

Global Head of Discovery and Investigational Safety at Novartis, Chairman of the EFPIA Innovative Medicines Strategy Priority Working Group

CV

 

carlo_incerti220.jpg

Carlo Incerti

Sr Vice President, Head of Global Medical Affairs Sanofi Genzyme

CV

 

 

paulus_stoffels220.jpg

Paul Stoffels

Chief Scientific Officer at Johnson & Johnson, Worldwide Chairman of Janssen Pharmaceutical Companies of Johnson & Johnson

CV

 

 

Governing Board decisions

  • List of decisions   taken by the IMI2 Governing Board from 1 January to 30 June 2017

  • List of decisions   taken by the IMI2 Governing Board from 1 July to 31 December 2016

  • List of decisions   taken by the IMI2 Governing Board from 1 January to 30 June 2016

  • List of decisions   taken by the IMI2 Governing Board from 24 September to 31 December 2015

  • List of decisions   taken by the IMI2 Governing Board from 1 July to 23 September 2015

  • List of decisions   taken by the IMI2 Governing Board from 1 January to 30 June 2015

  • List of decisions   taken by the IMI2 Governing Board in 2014 (from the establishment of IMI2 JU on 27 June 2014 to the end of 2014)